Boston University
Differential effects of statins on pancreatic beta-cell function: implications for risk of type 2 diabetes
Abstract
dc:description.abstractObjective. Despite advances in prevention and treatment, cardiovascular disease (CVD) remains a leading cause of mortality; thus, it is crucial for medicinal treatment. Statins are so far the best and first-choice of cholesterol treatment to prevent CVD. However, many clinical trials demonstrate that some statins may lead to increased risk for type 2 diabetes. Thus, this research investigated the effects of statins on glucose-stimulated insulin secretion from clonal ß-cells (INS-1). Methods. Clonal pancreatic ß-cells (INS-1) were cultured in low (4-5.5 mM) and high glucose (11mM) to study the effects of simvastatin and pitvastatin. For static incubations, statins were added to cultures for 1-3 days at 100-200 nM. Static incubations were performed over a glucose dose or a KCl dose at 12 mM glucose in the presence of 200 µM diazoxide. Kinetics of insulin secretion were measured from INS-1 cell spheres formed over two days culture in 4 mM glucose. Statins were added to spheres for the final day of culture. Kinetic measures of insulin secretion were made with an in-lab built perifusion system. Secretion was evaluated after following prolonged exposure to statins and insulin was assayed with an HTFR assay kit (Revvity). Results. Here, we examine the kinetics of GSIS after statin pretreatment in culture using the column perifusion technique. Results indicate that 24-hour statin treatment had a positive effect on oscillatory basal insulin secretion while also increasing secretion at 12 mM glucose and in response to 40 mM KCl. The effect of increasing oscillatory behavior of basal insulin secretion was more consistent with simvastatin exposure compared to pitavastatin. Conclusion. Based on our results we can conclude that simvastatin and pitvastatin both stimulate Glucose Stimulated Insulin Secretion (GSIS). After 24 hours of incubation, Simvastatin can amplify basal insulin secretion more extensively than the pitvastatin. Simvastatin may also inhibit insulin secretion due loss of content and loss of cholesterol leading to increased basal cytosolic calcium.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Nutrition and Metabolism
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Iftikhar, Anam
- Advisors dc:contributor.advisor
-
- Jude, Deeney T.
- Keith, Tornheim
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53498